← Back to Patent Explorer
US5312733A Expired / Lapsed US ⏱️ 0.0 years remaining

Developmental marker gene of CD4-CD8 thymocytes

Assignee: Research Development Foundation
•
Filing: 1991-04-11
•
Granted: 1994-05-17
•
Expires: 2011-04-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides novel DNA sequences, recombinant DNA (rDNA) molecules, processes for producing novel T-cell proteins expressed in T-cell development, the novel T-cell proteins in substantially pure form and antibodies which bind to the novel proteins. More particularly, it relates to novel DNA sequences expressed in appropriate hosts and the novel T-cell proteins produced in these hosts. The present invention also provides novel transmembrane proteins in substantially pure form, rDNA molecules encoding transmembrane proteins and processes for producing the novel transmembrane proteins. The DNA sequences and recombinant DNA molecules of this invention are characterized in that they are expressed by T lymphoma cells and have at least one of the following characteristics: (1) is expressed in normal thymus, activated spleen cells, or gut associated lymphoid tissue, (2) is expressed in ovarian tissue, normal liver and/or in a stage specific manner in embryonic development and (3) encode novel transmembrane proteins having multiple membrane spanning domains.

Inventors

  • 👤 Carol L. MacLeod

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 18:47
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; C07K16/30; A; A61; A61P; A61P37/00; C07K14/00; C07K14/435; C07K14/46; C07K14/705; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12P; C12P21/00; C07K2317/00; C07K2317/30; C07K2317/34

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 78 words
An expression vehicle which comprises a DNA sequence of a gene selected from the group consisting of 19.1 (seq. id. No. 1), 19.2 (seq. id. no. 2), 19.4 (seq. id. no. 3), 19.5 (seq. id. no. 4) and 20.5 (seq. id. no. 5) wherein said expression vehicle is capable of replication in a host which comprises, in operable linkage: a) an origin or replication; b) a promoter; and c) a DNA sequence coding for a T cell protein.
Claim 2
Dependent Claim 78 words
An expression vehicle which comprises a DNA sequence of a gene selected from the group consisting of 19.1 (seq. id. No. 1), 19.2 (seq. id. no. 2), 19.4 (seq. id. no. 3), 19.5 (seq. id. no. 4) and 20.5 (seq. id. no. 5) wherein said expression vehicle is capable of replication in a host which comprises, in operable linkage: a) an origin or replication; b) a promoter; and c) a DNA sequence coding for a T cell protein.
Claim 3
Dependent Claim 43 words
The expression vehicle of claim 1, wherein said expression vehicle is a plasmid capable of replication in a host which comprises, in operable linkage: a) an origin of replication; b) a promoter; and c) a DNA sequence coding for a T cell protein.
Claim 4
Dependent Claim 92 words
The expression vehicle of claim 1, wherein said expression vehicle is a phage or plasmid capable of replication in a prokaryotic host which comprises, in operable linkage: a) a prokaryotic origin of replication; b) a prokaryotic promoter; and c) a DNA sequence coding for a T lymphoma cell protein, wherein the protein is encoded by a gene selected from the group of cDNA clones consisting of 19.1 (seq. id. no. 1), 19.2 (seq. id. no. 2), 19.4 (seq. id. no. 3), 19.5 (seq. id. no. 4) and 20.5 (seq. id. no. 5).
Claim 5
Dependent Claim 86 words
A vector comprising a DNA sequence coding for a T lymphoma cell protein, wherein said T cell protein is encoded by a gene selected from the group consisting of 19.1 (seq. id. no. 1), 19.2 (seq. id. no. 2) 19.4 (seq. id. no. 3), 19.5 (seq. id. no. 4), and 20.5 (seq. id. 5) and said vector is capable of replication in a host which comprises, in operable linkage: a) an origin of replication; b) a promoter; and c) a DNA sequence coding for said gene.
Claim 6
Dependent Claim 86 words
A vector comprising a DNA sequence coding for a T lymphoma cell protein, wherein said T cell protein is encoded by a gene selected from the group consisting of 19.1 (seq. id. no. 1), 19.2 (seq. id. no. 2) 19.4 (seq. id. no. 3), 19.5 (seq. id. no. 4), and 20.5 (seq. id. 5) and said vector is capable of replication in a host which comprises, in operable linkage: a) an origin of replication; b) a promoter; and c) a DNA sequence coding for said gene.
Claim 7
Dependent Claim 22 words
The vector of claim 4 wherein said vector is isolated from the group consisting of a plasmid, a phage and a cosmid.
Claim 8
Dependent Claim 19 words
The vector of claim 5, wherein said vector is pT7T3-19.1 (seq. id. no. 1) having ATCC Accession number 68298.
Claim 9
Dependent Claim 19 words
The vector of claim 5, wherein said vector is pT7T3-19.2 (seq. id. no. 2) having ATCC Accession number 68299.
Claim 10
Dependent Claim 21 words
The vector of claim 5, wherein said vector is pT7T3-19.4 (seq. id. no. 3) having ATCC Accession numbers 68300 through 68302.
Claim 11
Dependent Claim 19 words
The vector of claim 5, wherein said vector is pT7T3-19.5 (seq. id. no. 4) having ATCC Accession number 68303.
Claim 12
Dependent Claim 19 words
The vector of claim 5, wherein said vector is pT7T3-20.5 (seq. id. no. 5) having ATCC Accession number 68305.
Claim 13
Dependent Claim 52 words
A host transformed with a recombinant DNA molecule, wherein said recombinant DNA molecule comprises a DNA sequence for a gene selected from the group consisting of 19.1 (seq. id. no. 1), 19.2 (seq. id. no. 2), 19.4 (seq. id. no. 3), 19.5 (seq. id. no. 4) and 20.5 (seq. id. no. 5).
Claim 14
Dependent Claim 52 words
A host transformed with a recombinant DNA molecule, wherein said recombinant DNA molecule comprises a DNA sequence for a gene selected from the group consisting of 19.1 (seq. id. no. 1), 19.2 (seq. id. no. 2), 19.4 (seq. id. no. 3), 19.5 (seq. id. no. 4) and 20.5 (seq. id. no. 5).
Claim 15
Dependent Claim 9 words
The host of claim 20, which is E. coli.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-05-16 1997-11-15 1998-05-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-05-16 2001-11-15 2002-05-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-05-16 2005-11-15 2006-05-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag